These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 8847680)
1. Is transdermal nicotine associated with cardiovascular risk? Thomas GA; Davies SV; Rhodes J; Russell MA; Feyerabend C; Säwe U J R Coll Physicians Lond; 1995; 29(5):392-6. PubMed ID: 8847680 [TBL] [Abstract][Full Text] [Related]
2. Nicotine effects on eicosanoid formation and hemostatic function: comparison of transdermal nicotine and cigarette smoking. Benowitz NL; Fitzgerald GA; Wilson M; Zhang Q J Am Coll Cardiol; 1993 Oct; 22(4):1159-67. PubMed ID: 7691912 [TBL] [Abstract][Full Text] [Related]
3. Transdermal nicotine for mildly to moderately active ulcerative colitis. A randomized, double-blind, placebo-controlled trial. Sandborn WJ; Tremaine WJ; Offord KP; Lawson GM; Petersen BT; Batts KP; Croghan IT; Dale LC; Schroeder DR; Hurt RD Ann Intern Med; 1997 Mar; 126(5):364-71. PubMed ID: 9054280 [TBL] [Abstract][Full Text] [Related]
4. Transdermal nicotine as maintenance therapy for ulcerative colitis. Thomas GA; Rhodes J; Mani V; Williams GT; Newcombe RG; Russell MA; Feyerabend C N Engl J Med; 1995 Apr; 332(15):988-92. PubMed ID: 7885427 [TBL] [Abstract][Full Text] [Related]
5. Transdermal nicotine for induction of remission in ulcerative colitis. McGrath J; McDonald JW; Macdonald JK Cochrane Database Syst Rev; 2004 Oct; (4):CD004722. PubMed ID: 15495126 [TBL] [Abstract][Full Text] [Related]
6. Transdermal nicotine for active ulcerative colitis. Pullan RD; Rhodes J; Ganesh S; Mani V; Morris JS; Williams GT; Newcombe RG; Russell MA; Feyerabend C; Thomas GA N Engl J Med; 1994 Mar; 330(12):811-5. PubMed ID: 8114833 [TBL] [Abstract][Full Text] [Related]
7. Transdermal nicotine compared with oral prednisolone therapy for active ulcerative colitis. Thomas GA; Rhodes J; Ragunath K; Mani V; Williams GT; Newcombe RG; Russell MA; Feyerabend C Eur J Gastroenterol Hepatol; 1996 Aug; 8(8):769-76. PubMed ID: 8864674 [TBL] [Abstract][Full Text] [Related]
8. Plasma fibrinogen in ulcerative colitis: the effect of disease activity and nicotine therapy in a randomised controlled trial. Ingram JR; Rhodes J; Collins PW; Williams GT; Newcombe RG; Thomas GA Dig Liver Dis; 2005 Nov; 37(11):832-7. PubMed ID: 16169302 [TBL] [Abstract][Full Text] [Related]
9. Which smokers are helped to give up smoking using transdermal nicotine patches? Results from a randomized, double-blind, placebo-controlled trial. Yudkin PL; Jones L; Lancaster T; Fowler GH Br J Gen Pract; 1996 Mar; 46(404):145-8. PubMed ID: 8731618 [TBL] [Abstract][Full Text] [Related]
10. Haemorheological, platelet and endothelial indices in relation to global measures of cardiovascular risk in hypertensive patients: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial. Spencer CG; Felmeden DC; Blann AD; Lip GY J Intern Med; 2007 Jan; 261(1):82-90. PubMed ID: 17222171 [TBL] [Abstract][Full Text] [Related]
11. Outcome of ulcerative colitis after treatment with transdermal nicotine. Guslandi M; Tittobello A Eur J Gastroenterol Hepatol; 1998 Jun; 10(6):513-5. PubMed ID: 9855069 [TBL] [Abstract][Full Text] [Related]
12. Dose-related cardiovascular and endocrine effects of transdermal nicotine. Zevin S; Jacob P; Benowitz NL Clin Pharmacol Ther; 1998 Jul; 64(1):87-95. PubMed ID: 9695723 [TBL] [Abstract][Full Text] [Related]
13. The influence of acute smoking on leucocytes, platelets and the endothelium. Blann AD; Kirkpatrick U; Devine C; Naser S; McCollum CN Atherosclerosis; 1998 Nov; 141(1):133-9. PubMed ID: 9863546 [TBL] [Abstract][Full Text] [Related]
14. Randomized, double-blind, placebo-controlled study of transdermal nicotine patch for smoking cessation. Perng RP; Hsieh WC; Chen YM; Lu CC; Chiang SJ J Formos Med Assoc; 1998 Aug; 97(8):547-51. PubMed ID: 9747065 [TBL] [Abstract][Full Text] [Related]
15. Acute effects of nicotine infusion on platelets in nicotine users with normal and impaired renal function. Whiss PA; Lundahl TH; Bengtsson T; Lindahl TL; Lunell E; Larsson R Toxicol Appl Pharmacol; 2000 Mar; 163(2):95-104. PubMed ID: 10698667 [TBL] [Abstract][Full Text] [Related]
16. [Transdermal nicotine treatment of ulcerative colitis: a survey of a Cochrane review]. Seidelin JB; Nielsen OH Ugeskr Laeger; 2006 Feb; 168(7):674-7. PubMed ID: 16494804 [No Abstract] [Full Text] [Related]
17. Transdermal nicotine for ulcerative colitis. Ando Y Ann Intern Med; 1997 Sep; 127(6):491-2; author reply 492-3. PubMed ID: 9313012 [No Abstract] [Full Text] [Related]
18. The influence of smoking and of oral and transdermal nicotine on blood pressure, and haematology and coagulation indices. Blann AD; Steele C; McCollum CN Thromb Haemost; 1997 Sep; 78(3):1093-6. PubMed ID: 9308759 [TBL] [Abstract][Full Text] [Related]
19. Plasma von Willebrand factor, fibrinogen and soluble P-selectin levels in paroxysmal, persistent and permanent atrial fibrillation. Effects of cardioversion and return of left atrial function. Li-Saw-Hee FL; Blann AD; Gurney D; Lip GY Eur Heart J; 2001 Sep; 22(18):1741-7. PubMed ID: 11511124 [TBL] [Abstract][Full Text] [Related]
20. The effect of mesalamine and nicotine in the treatment of inflammatory bowel disease. Bonapace CR; Mays DA Ann Pharmacother; 1997; 31(7-8):907-13. PubMed ID: 9220055 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]